XML 19 R9.htm IDEA: XBRL DOCUMENT
v3.20.2

Condensed Consolidated Financial Statements Details | 6 Months Ended
--- | ---
Jun. 30, 2020
Condensed Consolidated Financial Statements Details |
Condensed Consolidated Financial Statements Details | 3. Condensed Consolidated Financial Statements Details Equity Securities As of June 30, 2020 and December 31, 2019, equity securities consisted of an investment in Rezolute’s common stock of $0.5 million and $0.7 million, respectively (Note 4). For the three and six months ended June 30, 2020 the Company recognized a gain of $0.1 million and a loss of $0.2 million, respectively, due to the change in fair value of its investment in Rezolute’s common stock in the other income (expense), net line item of the condensed consolidated statements of operations and comprehensive loss, and the Company recognized $31,000 and $0.7 million in gains for the three and six months ended June 30, 2019. Accrued and Other Liabilities Accrued and other liabilities consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ |  | 2020 |  | 2019
Accrued legal and accounting fees | ​ | $ | 378 | ​ | $ | 256
Accrued payroll and other benefits | ​ |  | 119 | ​ |  | 231
Interest payable | ​ |  | 56 | ​ |  | 69
Accrued incentive compensation | ​ |  | 24 | ​ |  | 332
Other | ​ |  | 28 | ​ |  | 57
Total | ​ | $ | 605 | ​ | $ | 945
​ Net Loss Per Share Attributable to Common Stockholders The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Numerator |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Net loss available to common stockholders | ​ | $ | (3,533) | ​ | $ | (4,072) | ​ | $ | (8,291) | ​ | $ | (839)
​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Denominator | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders | ​ |  | 10,824 | ​ |  | 8,725 | ​ |  | 10,292 | ​ |  | 8,716
Basic and diluted net loss per share of common stock | ​ | $ | (0.33) | ​ | $ | (0.47) | ​ | $ | (0.81) | ​ | $ | (0.10)
​ Potentially dilutive securities are excluded from the calculation of diluted net loss per share available to common stockholders if their inclusion is anti-dilutive. ​ The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2020 |  | 2019 |  | 2020 |  | 2019
Convertible preferred stock |  | 5,196 |  | 6,256 |  | 5,726 |  | 6,256
Common stock options |  | 564 |  | 1,934 |  | 578 |  | 1,861
Warrants for common stock |  | 19 |  | 28 |  | 19 |  | 27
Total |  | 5,779 |  | 8,218 |  | 6,323 |  | 8,144
​

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Consolidated financial statement detail. + References No definition available. + Details
Name: | xoma_ConsolidatedFinancialStatementDetailAbstract
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration